Get started
Author

Norimitsu Kasahara

Observed names: Kasahara, Norimitsu, N. Kasahara, NORIMITSU KASAHARA
Institution: Gunma University
ORCID: 0000-0001-6971-7411
Observed ORCID: 0000-0001-6971-7411
OpenAlex ID: A5091454845
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma
2018 · Norimitsu Kasahara, Kyoichi Kaira, et al. · Lung Cancer · 54
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
2020 · Ou Yamaguchi, Hisao Imai, et al. · Cancer Chemotherapy and Pharmacology · 47
Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1
2019 · NORIMITSU KASAHARA, NORIAKI SUNAGA, et al. · Anticancer Research · 36
PDF
Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer
2019 · Norimitsu Kasahara, Kyoichi Kaira, et al. · Lung Cancer · 31
Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
2021 · Noriaki Sunaga, Yosuke Miura, et al. · Cancers · 21
PDF
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer
2017 · Norimitsu Kasahara, Hirotsugu Kenmotsu, et al. · Lung Cancer · 16
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma
2017 · Norimitsu Kasahara, Kazushige Wakuda, et al. · Molecular and Clinical Oncology · 14
PDF
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment
2020 · Norimitsu Kasahara, Hisao Imai, et al. · Thoracic Cancer · 13
PDF
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study
2020 · Norimitsu Kasahara, Noriaki Sunaga, et al. · Supportive Care in Cancer · 13
Accumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis
2018 · Keisuke Murata, Yasuhiko Koga, et al. · Journal of Thoracic Disease · 13
PDF
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
2022 · Ou Yamaguchi, Kyoichi Kaira, et al. · Scientific Reports · 12
PDF
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
2023 · Ou Yamaguchi, Norimitsu Kasahara, et al. · Scientific Reports · 9
PDF
Efficacy and safety of S ‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis
2020 · Hisao Imai, Hiroyuki Minemura, et al. · Thoracic Cancer · 9
PDF
Dual inhibition of MEK and p38 impairs tumor growth in KRAS‑mutated non‑small cell lung cancer
2019 · Noriaki Sunaga, Yosuke Miura, et al. · Oncology Letters · 9
PDF
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
2015 · Norimitsu Kasahara, Hisao Imai, et al. · Radiology and Oncology · 8
PDF
Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report
2018 · Yumeka Sasaki, Yasuhiko Koga, et al. · Journal of Nippon Medical School · 7
PDF
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis
2022 · Noriaki Sunaga, Yasuhiko Koga, et al. · Canadian Respiratory Journal · 6
PDF
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
2021 · Ikuo Wakamatsu, Masakiyo Yatomi, et al. · Radiology Case Reports · 6
PDF
Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
2020 · Tomomi Masuda, Noriaki Sunaga, et al. · Thoracic Cancer · 6
PDF
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer
2023 · Kyoichi Kaira, Ou Yamaguchi, et al. · Cancer Imaging · 5
PDF
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer
2019 · KYOICHI KAIRA, HISAO IMAI, et al. · Anticancer Research · 5
PDF
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation
2023 · Mari Sato, Masakiyo Yatomi, et al. · Respiratory Medicine Case Reports · 4
Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer
2019 · Yosuke Miura, Norimitsu Kasahara, et al. · Translational Cancer Research · 4
PDF
The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome
2017 · Yoshimasa Hachisu, Yasuhiko Koga, et al. · Internal Medicine · 2
PDF
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib
2024 · Kazutaka Takehara, Yasuhiko Koga, et al. · Respiratory Investigation · 1
Works count: 38
Citation count: 353
H-index: 11
I10-index: 11
Year
Topic
Type